Case Studies - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Case Studies

JDA Software Group, Inc.

April 1, 2009

Merck Serono?s biggest challenge was the integration of two very different supply chains for traditional pharmaceuticals and biotechnology-based pharmaceuticals.

Clean utilities at Leo Pharma

January 6, 2009

Leo Pharma at Vernouillet in France produces the anti-thrombotic Innohep® in pre-filled syringes, and blister packed tablets of the diuretics Burinex® and Centyl® and the antibiotic Fucidine®.

Global Information Management Solution from SDL

January 6, 2009

The following case study looks at how SDL?s Global Information Management System (GIM) has enabled the European Medicines Agency (EMEA) and GlaxoSmithKline (GSK) to work together to help perfect the new European healthcare standard, Product Information Management, and create a streamlined, efficient process for the approval of new drugs and products.

Introducing an automated and validated calibration system

July 28, 2008

AstraZeneca Sweden Operations

11,000 calibrations a year, made mostly with Beamex calibration equipment

July 28, 2008

Eli Lilly and Compny Limited, Speke Operations United Kingdom

IT Governance smoothes the way to IS027001 certification for IMS Hospital Group

July 28, 2008

IT Governance smoothes the way to IS027001 certification for IMS Hospital Group.

Paperless calibaration system — the choice of an enviornmentally conscious pharmaceutical company

July 23, 2008

Paperless calibaration system — the choice of an enviornmentally conscious pharmaceutical company

Modular Cleanroom Construction Makes the Difference at St. Georges Hospital

July 23, 2008

Modular Cleanroom Construction Makes the Difference at St. Georges Hospital

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here